Vasorelaxant effect of Cinnamomi ramulus ethanol extract via Rho-kinase signaling pathway

American Journal of Chinese Medicine

Volumn 39, Issue 5, 2011, Pages 867-878

  Kang, Yun Hwan ^a   Shin, Heung Mook ^a  

^a Dongguk University   (South Korea)

Author keywords

Cinnamomi ramulus Ethanol Extract (CRE); CPI 17; MYPT 1; Rho Kinase Signaling Pathway; Vasodilatory Effect

Indexed keywords

CALPEPTIN; CINNAMOMI RAMULUS ETHANOL EXTRACT; MYOSIN; MYOSIN LIGHT CHAIN; MYOSIN LIGHT CHAIN 20; MYOSIN PHOSPHATASE TARGETING SUBUNIT 1; PHENYLEPHRINE; PLANT EXTRACT; PROTEIN KINASE C; PROTEIN KINASE C POTENTIATED PHOSPHATASE INHIBITOR PROTEIN 17; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; CINNAMOMI RAMULUS; CINNAMON; CONTROLLED STUDY; DOWNSTREAM PROCESSING; DRUG MECHANISM; HUMAN; HUMAN CELL; MALE; MEDICINAL PLANT; NONHUMAN; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VASODILATATION;

ALGAL PROTEINS; ANIMALS; DISEASE MODELS, ANIMAL; ETHANOL; HUMANS; HYPERTENSION; MALE; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; RHO-ASSOCIATED KINASES; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; VASODILATOR AGENTS;

EID: 80052634020     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X11009263     Document Type: Article

References (29)

1. Amano, M., M. Ito, K. Kimura, Y. Fukata, K. Chihara, T. Nakano, Y. Matsuura and K. Kaibuchi. Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J. Biol. Chem. 271: 20246-20249, 1996. (Pubitemid 26281788)
2. Chan, C.K., J.C. Mak, R.Y. Man and P.M. Vanhoutte. Rho kinase inhibitors prevent endotheliumdependent contractions in the rat aorta. J. Pharmacol. Exp. Ther. 329: 820-826, 2009.
3. Chobanian, A.V., G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, J.L. Jr. Izzo, D.W. Jones, B.J. Materson, S. Oparil, J.T. Wright, Jr., E.J. Roccella and the National High Blood Pressure Education Program Coordinating Committee. The Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42: 1206-1252, 2003. (Pubitemid 37553153)
4. Escobar, E. Hypertension and coronary heart disease. J. Hum. Hypertens. 16(Suppl. 1): S61-63, 2002. (Pubitemid 34441139)
5. Fukata, Y., N. Oshiro, N. Kinoshita, Y. Kawano, Y. Matsuoka, V. Bennett, Y. Matsuura and K. Kaibuchi. Phosphorylation of adducin by Rho-kinase plays a crucial role in cell motility. J. Biol. Chem. 145: 347-361, 1999. (Pubitemid 29198306)
6. Hassani, K., M. Navidbakhsh and M. Rostami. Modeling of the aorta artery aneurysms and renal artery stenosis using cardiovascular electronic system. Biomed. Eng. Online 6: 22-32, 2007.
7. Horowitz, A., C.B. Menice, R. Laporte and K.G. Morgan. Mechanisms of smooth muscle contraction. Physiol. Rev. 76: 967-1003, 1996. (Pubitemid 26346813)
8. Jeon, S.B., G. Kim, J.I. Kim, Y.M. Seok, S.H. Kim, K. Suk, H.M. Shin, Y.H. Lee and I.K. Kim. Flavone inhibits vascular contraction by decreasing phosphorylation of the myosin phosphatase target subunit. Clin. Exp. Pharmacol. Physiol. 34: 1116-1120, 2007. (Pubitemid 47416344)
9. Kassaï, B., J.P. Boissel, M. Cucherat, F. Boutitie and F. Gueyffier. Treatment of high blood pressure and gain in event-free life expectancy. Vasc. Health Risk Manag. 1: 163-169, 2005.
10. Kim, J.B. and H.M. Shin. Vasodilation of ethanol extract of Cinnamomi Ramulus via voltage dependent Ca2+ channel blockage. Korean J. Orient. Med. Physiol. Pathol. 24: 592-597, 2010.
11. Kimura, K., Y. Fukata, Y. Matsuoka, V. Bennett, Y. Matsuura, K. Okawa, A. Iwamatsu and K. Kaibuchi. Regulation of the association of adducin with actin filaments by Rho-associated kinase (Rho-kinase) and myosin phosphatase. J. Biol. Chem. 273: 5542-5548, 1998. (Pubitemid 28124020)
12. Kitazawa, T., M. Eto, T.P. Woodsome and M. Khalequzzaman. Phosphorylation of the myosin phosphatase targeting subunit and CPI-17 during Ca2+ sensitization in rabbit smooth muscle. J. Physiol. 546: 879-889, 2003. (Pubitemid 36204521)
13. Kopunek, S.P., K.M. Michael, M. Shaughnessy, B. Resnick, E.S. Nahm, J. Whitall, A. Goldberg and R.F. Macko. Cardiovascular risk in survivors of stroke. Am. J. Prev. Med. 32: 408-412, 2007. (Pubitemid 46661978)
14. Liu, P.Y. and J.K. Liao. A method for measuring Rho kinase activity in tissues and cells. Methods Enzymol. 439: 181-189, 2008.
15. Loirand, G., P. Gued́rin and P. Pacaud. Rho kinases in cardiovascular physiology and pathophysiology. Circ. Res. 98: 322-334, 2006.
16. Nakagawa, O., K. Fujisawa, T. Ishizaki, Y. Saito, K. Nakao and S. Narumiya. ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice. FEBS Lett. 392: 189-193, 1996. (Pubitemid 26276745)
17. Niiro, N., Y. Koga and M. Ikebe. Agonist-induced changes in the phosphorylation of the myosinbinding subunit of myosin light chain phosphatase and CPI17, two regulatory factors of myosin light chain phosphatase, in smooth muscle. Biochem. J. 369: 117-128, 2003. (Pubitemid 36174131)
18. Park, H.J., J.S. Lee, J.D. Lee, N.J. Kim, J.H. Pyo, J.M. Kang, I.L. Choe, S.Y. Kim, B.S. Shim, J.H. Lee and S. Lim. The anti-inflammatory effect of Cinnamomi Ramulus. J. Korean Orient. Med. 26: 140-151, 2005.
19. Pfitzer, G. Invited review: Regulation of myosin phosphorylation in smooth muscle. J. Appl. Physiol. 91: 497-503, 2001. (Pubitemid 32574761)
20. Ponnuchamy, B. and R.A. Khalil. Cellular mediators of renal vascular dysfunction in hypertension. Am. J. Physiol. Regul. Integr. Comp. Physiol. 296: R1001-R1018, 2009.
21. Schoenwaelder, S.M. and K. Burridge. Evidence for a calpeptin-sensitive protein-tyrosine phosphatase upstream of the small GTPase Rho. A novel role for the calpain inhibitor calpeptin in the inhibition of protein-tyrosine phosphatases. J. Biol. Chem. 274: 14359-14367, 1999.
22. Seok, Y.M., I. Baek, Y.H. Kim, Y.S. Jeong, I.J. Lee, D.H. Shin, Y.H. Hwang and I.K. Kim. Isoflavone attenuates vascular contraction through inhibition of the RhoA/Rho-kinase signaling pathway. J. Pharmacol. Exp. Ther. 326: 991-998, 2008.
23. Shimokawa, H. and A. Takeshita. Rho-kinase is an important therapeutic target in cardiovascular medicine. Arterioscler. Thromb. Vasc. Biol. 25: 1767-1775, 2005. (Pubitemid 41243442)
24. Tamaru, S., T. Fukuta, K. Kaibuchi, Y. Matsuoka, H. Shiku and M. Nishikawa. Rho-kinase induces association of adducin with the cytoskeleton in platelet activation. Biochem. Biophys. Res. Commun. 332: 347-351, 2005. (Pubitemid 40724984)
25. Terzuoli, L., E. Marinello, B. Frosi, I. Ciari and B. Porcelli. Nitric oxide levels in patients with atheromatous carotid plaque. Biomed. Pharmacother. 62: 325-327, 2008. (Pubitemid 351749773)
26. Uehata, M., T. Ishizaki, H. Satoh, T. Ono, T. Kawahara, T. Morishita, H. Tamakawa, K. Yamagami, J. Inui, M. Maekawa and S. Narumiya. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389: 990-994, 1997. (Pubitemid 27485693)
27. Wang, Y., X.R. Zheng, N. Riddick, M. Bryden, W. Baur, X. Zhang and H.K. Surks. ROCK isoform regulation of myosin phosphatase and contractility in vascular smooth muscle cells. Circ. Res. 104: 531-540, 2009.
28. Wibberley, A., Z. Chen, E. Hu, J.P. Hieble and T.D. Westfall. Expression and functional role of Rhokinase in rat urinary bladder smooth muscle. Br. J. Pharmacol. 138: 757-766, 2003. (Pubitemid 36390631)
29. Wilson, D.P., M. Susnjar, E. Kiss, C. Sutherland and M.P. Walsh. Thromboxane A2-induced contraction of rat caudal arterial smooth muscle involves activation of Ca2+ entry and Ca2+ sensitization: Rho-associated kinase-mediated phosphorylation of MYPT1 at Thr-855, but not Thr-697. Biochem. J. 389: 763-774, 2005. (Pubitemid 41121989)